Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.
Nolan D; Phillips E; Mallal S; Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America, 2006, vol. 42, issue 3, p 408, ISSN 15376591. ISBN 15376591.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef